If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThg Regulatory News (THG)

Share Price Information for Thg (THG)

Share Price is delayed by 15 minutes
Get Live Data
31.60    -0.20 (-0.63%)
Bid:
31.62
Ask:
31.82
Spread: 0.20 (0.633%)
Market Cap: £501.45m
THG Live PriceLast checked at - London Stock Exchange

Intraday Thg Share Chart

Equity Raise Post-Transaction Report

15 Oct 2024 16:29

RNS Number : 2983I
THG PLC
15 October 2024
Β 

Β 

Β 

For immediate release

Β 

Β 

15 October 2024

THG PLC

Equity Raise Post-Transaction Report

Β 

In accordance with the Statement of Principles (November 2022) published by the Pre-Emption Group, THG PLC ("THG", the "Company"), announces the following post transaction report in connection with the Company's non-pre-emptive issue of equity securities, as announced on 11 October 2024.

Β 

Terms defined in the placing announcement issued on 10 October 2024 (the "Placing Announcement") have the same meanings in this announcement unless the context provides otherwise.

Β 

Name of Issuer

THG PLC

Transaction Details

The Company issued 194,722,333 new Ordinary Shares in total pursuant to the Fundraise (comprising 138,265,306 Placing Shares, 45,408,163 Subscription Shares and 11,048,864 Retail Offer Shares), representing approximately 14.6% of the Company's existing issued Ordinary Shares prior to the Fundraise.

Β 

Settlement and admission of the Placing Shares, the Subscription Shares and the Retail Offer Shares took place at 8.00 am on 15 October 2024.

Use of Proceeds

As set out in the Placing Announcement and the result of placing announcement issued on 11 October 2024, approximately Β£75 million of net institutional proceeds of the Fundraise will be used to provide IngenuityCo with sufficient medium-term funding (in tandem with appropriate standalone debt issuance plans) and the net proceeds raised in excess of Β£75 million will be used for general corporate purposes.

Quantum of Proceeds

The aggregate proceeds from the Fundraise amounted to approximately Β£95.4 million.

Β 

Discount

The Placing Price of 49 pence represented a discount of approximately 5.2 per cent. to the closing price on 10 October 2024.

Allocations

Soft pre-emption has been adhered to in the allocations process, where possible. Management was involved in the allocations process, which has been carried out in compliance with the MIFID II Allocation requirements.

Consultation

The Company consulted with a number of its major shareholders prior to the Fundraise, with certain of the Company's long-term shareholders indicating their intention to subscribe for, in aggregate, Β£33 million of new Ordinary Shares at the Placing Price pre-launch as set out in the Placing Announcement.

Retail Investors

The Fundraise included a Retail Offer via the PrimaryBid platform, for a total of 11,048,864 Retail Offer Shares, raising gross proceeds of approximately Β£5.4 million.

Β 

Retail investors, who participated in the Retail Offer, were able to do so at the same Placing Price as all other investors participating in the Fundraise.

Β 

The Retail Offer was made available to existing shareholders and new investors in the UK. Investors were able to participate through PrimaryBid's platform via its partner network (covering 60+ FCA registered intermediaries) and through PrimaryBid's free-to-use direct channel. Investors had the ability to participate in this transaction through ISAs and SIPPs, as well as General Investment Accounts (GIAs). This combination of participation routes meant that, to the extent practicable on the transaction timetable, eligible UK retail investors (including certificated retail shareholders) had the opportunity to participate in the Capital Raise alongside institutional investors.

Β 

Β 

Β 

Β 

For further information, please contact:

Β 

Investor Enquiries:

Greg Feehely, SVP Investor Relations

Kate Grimoldby, Director of Investor Relations and Strategic Projects

Investor.Relations@thg.com

Media enquiries:

Β 

Sodali & Co - Financial PR adviser

Victoria Palmer-Moore / Russ Lynch

+44 (0)20 7250 1446

thg@sodali.com

THG PLC

Viki Tahmasebi

Viki.tahmasebi@thg.com

Barclays (Joint Global Coordinator, Joint Bookrunner and Joint Corporate Broker):

Alastair Blackman

Dominic Harper

Callum West

+44 (0)20 7623 2323

Jefferies International Limited (Joint Global Coordinator, Joint Bookrunner and Joint Corporate Broker):

Philip Noblet

Ed Matthews

Gavriel Lambert

+44 (0)20 7029 8000

Peel Hunt LLP (Joint Bookrunner)Β George SellarΒ Sohail AkbarΒ Andrew Clark

+44 (0)20 7418 8900

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
IOEFFAFIIELSEES
Date   Source Headline
7th Jun 20133:31 pmRNSDirector/PDMR Shareholding
5th Jun 20137:00 amRNSHalf Yearly Report
22nd May 20137:55 amRNSAcquisition of Remaining Residential Assets
20th May 201310:19 amRNSNotice of Results
13th May 20137:00 amRNSCompletion of Foodstore Developments
28th Feb 20134:40 pmRNSResult of AGM
18th Feb 201310:31 amRNSDirector/PDMR Shareholding
12th Feb 201310:01 amRNSDirector/PDMR Shareholding
8th Feb 20134:44 pmRNSSale of Residential Portfolio
6th Feb 201310:23 amRNSDirector/PDMR Shareholding
4th Feb 20137:00 amRNSStudent accommodation forward funding and pre-sale
23rd Jan 20137:00 amRNSAnnual Financial Report and Notice of AGM
11th Dec 20127:00 amRNSFinal Results
30th Nov 20127:00 amRNSNotice of Results
14th Nov 20127:00 amRNS£30m Leisure Scheme Development in Darlington
29th Oct 20127:00 amRNSPre-sale of Southampton Development
28th Sep 20121:22 pmRNSDirector/PDMR Shareholding
19th Sep 20127:00 amRNSAcquisition of new foodstore development
10th Sep 20125:14 pmRNSCapital Reduction
2nd Aug 201211:20 amRNSResult of EGM
13th Jul 201210:26 amRNSCirc re. Reduction of Share Premium Account
14th Jun 20128:19 amRNSDirector/PDMR Shareholding
13th Jun 20128:07 amRNSDirector/PDMR Shareholding
12th Jun 20127:00 amRNSHalf Yearly Report
6th Jun 20123:20 pmRNSNotice of Results
8th May 20127:00 amRNSStrong Progress Across Foodstore Developments
5th Apr 201212:01 pmRNS£35m Forward Funding for Sainsbury's in Sunderland
30th Mar 20122:46 pmRNSDirector/PDMR Shareholding
27th Mar 201210:32 amRNSDirector/PDMR Shareholding
8th Mar 20125:16 pmRNSDirector/PDMR Shareholding
8th Mar 20122:25 pmRNSDirector/PDMR Shareholding
7th Mar 201212:37 pmRNSSale of Residential Portfolio for £75.35m
2nd Mar 201212:04 pmRNSResult of AGM - Replacement
2nd Mar 20127:00 amRNSLetting and Sale at Brabazon Office Park, Bristol
1st Mar 20123:42 pmRNSResult of AGM
17th Feb 20124:25 pmRNSDirector/PDMR Shareholding
13th Feb 20123:39 pmRNSResidential Update
7th Feb 20122:28 pmRNSAnnual Financial Report and Notice of AGM
30th Jan 20127:00 amRNSDevelopment Agreement with Sainsbury's
6th Jan 20127:00 amRNSFinal Results
3rd Jan 20122:15 pmRNSNotice of Results
15th Nov 20116:07 pmRNSClarification / Additional Disclosure
4th Nov 20117:00 amRNSMarketing of Residential Investment Business
20th Sep 20117:00 amRNSPlanning recommendation for foodstore
7th Sep 20117:00 amRNSPlanning recommendation for two foodstore schemes
30th Jun 20113:10 pmRNSDirector/PDMR Shareholding
28th Jun 20117:00 amRNSAcquisition of Foodstore Development Site
16th Jun 20111:25 pmRNSDirector/PDMR Shareholding
8th Jun 20117:00 amRNSAcquisitions
25th May 20113:08 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.